Björk P - Search Results

1

[New marker in thrombotic thrombocytopenic purpura].

Gøtze JP, Hillarp A, Lindblom A, Björk P, Strandberg K, Nielsen LB. Gøtze JP, et al. Among authors: bjork p. Ugeskr Laeger. 2008 Aug 11;170(33):2446-9. Ugeskr Laeger. 2008. PMID: 18761827 Review. Danish.

2

[ADAMTS13--actor and marker in thrombotic microangiopathy].

Gøtze JP, Lindblom A, Björk P, Nielsen LB, Strandberg K, Manea M, Hillarp A. Gøtze JP, et al. Among authors: bjork p. Lakartidningen. 2008 Apr 9-15;105(15):1092-5. Lakartidningen. 2008. PMID: 18561751 Review. Swedish. No abstract available.

3

Minor stroke as singular manifestation of hereditary thrombotic thrombocytopenic purpura in a young man.

Lindblom A, Thorsen S, Hillarp A, Björk P. Lindblom A, et al. Among authors: bjork p. Int Angiol. 2009 Aug;28(4):336-9. Int Angiol. 2009. PMID: 19648879

4

Clinical-scale generation of strongly CD83-expressing dendritic cells using extracorporeal photopheresis.

Bredberg A, Jonsson S, Lindblom A, Björk P. Bredberg A, et al. Among authors: bjork p. Photodermatol Photoimmunol Photomed. 2007 Aug;23(4):113-9. doi: 10.1111/j.1600-0781.2007.00285.x. Photodermatol Photoimmunol Photomed. 2007. PMID: 17598863

5

ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura.

Manea M, Kristoffersson A, Tsai HM, Zhou W, Winqvist I, Oldaeus G, Billström R, Björk P, Holmberg L, Karpman D. Manea M, et al. Among authors: bjork p. Eur J Pediatr. 2007 Mar;166(3):249-57. doi: 10.1007/s00431-006-0354-2. Epub 2006 Dec 24. Eur J Pediatr. 2007. PMID: 17187257 Free PMC article.

6

Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura.

Manea M, Kristoffersson A, Schneppenheim R, Saleem MA, Mathieson PW, Mörgelin M, Björk P, Holmberg L, Karpman D. Manea M, et al. Among authors: bjork p. Br J Haematol. 2007 Sep;138(5):651-62. doi: 10.1111/j.1365-2141.2007.06694.x. Epub 2007 Jul 12. Br J Haematol. 2007. PMID: 17627784 Free article.

7

Release of immunoreactive canine leukocyte elastase normally and in endotoxin and pancreatitic shock.

Axelsson L, Bergenfeldt M, Björk P, Olsson R, Ohlsson K. Axelsson L, et al. Among authors: bjork p. Scand J Clin Lab Invest. 1990 Feb;50(1):35-42. doi: 10.1080/00365519009091562. Scand J Clin Lab Invest. 1990. PMID: 1690443

8

Release of dog polymorphonuclear leukocyte cathepsin G, normally and in endotoxin and pancreatitic shock. Isolation and partial characterization of dog polymorphonuclear leukocyte cathepsin G.

Björk P, Axelsson L, Ohlsson K. Björk P, et al. Biol Chem Hoppe Seyler. 1991 Jun;372(6):419-26. doi: 10.1515/bchm3.1991.372.1.419. Biol Chem Hoppe Seyler. 1991. PMID: 1910580

9

The elimination of secretory leukocyte protease inhibitor (SLPI) after intravenous injection in dog and man.

Bergenfeldt M, Björk P, Ohlsson K. Bergenfeldt M, et al. Among authors: bjork p. Scand J Clin Lab Invest. 1990 Nov;50(7):729-37. doi: 10.1080/00365519009091066. Scand J Clin Lab Invest. 1990. PMID: 2293334

10

Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man.

Björk P, Axelsson L, Bergenfeldt M, Ohlsson K. Björk P, et al. Scand J Clin Lab Invest. 1988 Apr;48(2):205-11. doi: 10.3109/00365518809085414. Scand J Clin Lab Invest. 1988. PMID: 2451859

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page